pubmed-article:18413401 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18413401 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:18413401 | lifeskim:mentions | umls-concept:C0036751 | lld:lifeskim |
pubmed-article:18413401 | lifeskim:mentions | umls-concept:C0033978 | lld:lifeskim |
pubmed-article:18413401 | lifeskim:mentions | umls-concept:C0041177 | lld:lifeskim |
pubmed-article:18413401 | lifeskim:mentions | umls-concept:C0114838 | lld:lifeskim |
pubmed-article:18413401 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
pubmed-article:18413401 | lifeskim:mentions | umls-concept:C0031572 | lld:lifeskim |
pubmed-article:18413401 | lifeskim:mentions | umls-concept:C1167622 | lld:lifeskim |
pubmed-article:18413401 | lifeskim:mentions | umls-concept:C0205246 | lld:lifeskim |
pubmed-article:18413401 | lifeskim:mentions | umls-concept:C0040399 | lld:lifeskim |
pubmed-article:18413401 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:18413401 | pubmed:dateCreated | 2008-5-1 | lld:pubmed |
pubmed-article:18413401 | pubmed:abstractText | There is circumstantial evidence for the involvement of serotonergic and dopaminergic systems in the pathophysiology of social anxiety disorder. In the present study, using SPECT imaging we examined the (123)I-beta-(4-iodophenyl)-tropane binding potential for the serotonin and dopamine transporters in patients with a generalized social anxiety disorder and in age- and sex-matched healthy controls. | lld:pubmed |
pubmed-article:18413401 | pubmed:language | eng | lld:pubmed |
pubmed-article:18413401 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18413401 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18413401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18413401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18413401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18413401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18413401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18413401 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18413401 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18413401 | pubmed:month | May | lld:pubmed |
pubmed-article:18413401 | pubmed:issn | 0161-5505 | lld:pubmed |
pubmed-article:18413401 | pubmed:author | pubmed-author:van... | lld:pubmed |
pubmed-article:18413401 | pubmed:author | pubmed-author:StevensHenkH | lld:pubmed |
pubmed-article:18413401 | pubmed:author | pubmed-author:van der... | lld:pubmed |
pubmed-article:18413401 | pubmed:author | pubmed-author:van... | lld:pubmed |
pubmed-article:18413401 | pubmed:author | pubmed-author:WestenbergHer... | lld:pubmed |
pubmed-article:18413401 | pubmed:author | pubmed-author:van VeenJ... | lld:pubmed |
pubmed-article:18413401 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18413401 | pubmed:volume | 49 | lld:pubmed |
pubmed-article:18413401 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18413401 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18413401 | pubmed:pagination | 757-63 | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:meshHeading | pubmed-meshheading:18413401... | lld:pubmed |
pubmed-article:18413401 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18413401 | pubmed:articleTitle | Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT. | lld:pubmed |
pubmed-article:18413401 | pubmed:affiliation | Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands. n.j.a.van_der_wee@lumc.nl | lld:pubmed |
pubmed-article:18413401 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18413401 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18413401 | lld:pubmed |